Decision Diagnostics Corp. was founded with the mission to develop innovative smartphone applications for the remote access and management of medical records. The company focuses on providing solutions for the medical insurance and pharmacy benefits management segments of the healthcare market. Their primary products include smartphone apps that enable physicians to carry, access, and update their patients' medical records, as well as low-cost home testing devices and test strips compatible with legacy meters.
Notable affiliated entities include PharmaTech Solutions Inc., which is actively seeking distributorship candidates for products like GenViro!®, GenUltimate!®, GenUltimate! TBG®, and GenUltimate Precis!®. Decision Diagnostics has successfully filled distributorship positions in regions such as the Russian Federation, post-Brexit UK, and several Southeast Asian countries. The company's key achievements include expanding its market reach and providing cost-effective healthcare solutions, significantly impacting the accessibility and management of medical records and home testing.
Quick Facts
When was Decision Diagnostics' last funding round?
Decision Diagnostics' most recent funding round was for $12.5M (USD) in December 2013.
How much disclosed funding has Decision Diagnostics raised?
As of Dec 19, 2013, Decision Diagnostics has disclosed funding of $12.5M (USD).
